Capital Expenditures - PureTech Health PLC (NASDAQ:PRTC) - Alpha Spread
P

PureTech Health PLC
NASDAQ:PRTC

Watchlist Manager
PureTech Health PLC
NASDAQ:PRTC
Watchlist
Price: 19.43 USD 0.08% Market Closed
Market Cap: 465m USD
Have any thoughts about
PureTech Health PLC?
Write Note

PureTech Health PLC
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PureTech Health PLC
Capital Expenditures Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
P
PureTech Health PLC
NASDAQ:PRTC
Capital Expenditures
-$245k
CAGR 3-Years
64%
CAGR 5-Years
44%
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Capital Expenditures
-$858m
CAGR 3-Years
1%
CAGR 5-Years
-6%
CAGR 10-Years
-4%
Gilead Sciences Inc
NASDAQ:GILD
Capital Expenditures
-$572m
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
-5%
Amgen Inc
NASDAQ:AMGN
Capital Expenditures
-$965m
CAGR 3-Years
-14%
CAGR 5-Years
-8%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Capital Expenditures
-$481.8m
CAGR 3-Years
-12%
CAGR 5-Years
-47%
CAGR 10-Years
-23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Capital Expenditures
-$886.1m
CAGR 3-Years
-15%
CAGR 5-Years
-20%
CAGR 10-Years
-14%

See Also

What is PureTech Health PLC's Capital Expenditures?
Capital Expenditures
-245k USD

Based on the financial report for Dec 31, 2023, PureTech Health PLC's Capital Expenditures amounts to -245k USD.

What is PureTech Health PLC's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
44%

Over the last year, the Capital Expenditures growth was 89%. The average annual Capital Expenditures growth rates for PureTech Health PLC have been 64% over the past three years , 44% over the past five years .

Back to Top